Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 110,014,496
  • Shares Outstanding, K 254,034
  • Annual Sales, $ 12,001 M
  • Annual Income, $ 3,953 M
  • EBIT $ 4,173 M
  • EBITDA $ 4,383 M
  • 60-Month Beta 0.31
  • Price/Sales 9.60
  • Price/Cash Flow 25.82
  • Price/Book 6.17

Options Overview Details

View History
  • Implied Volatility 34.97% (+0.03%)
  • Historical Volatility 37.59%
  • IV Percentile 71%
  • IV Rank 51.35%
  • IV High 47.19% on 04/08/25
  • IV Low 22.08% on 08/27/25
  • Expected Move (DTE 2) 10.80 (2.44%)
  • Put/Call Vol Ratio 0.86
  • Today's Volume 2,530
  • Volume Avg (30-Day) 3,820
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 42,508
  • Open Int (30-Day) 50,302
  • Expected Range 432.37 to 453.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 33 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 3.88
  • Number of Estimates 7
  • High Estimate 4.37
  • Low Estimate 3.51
  • Prior Year 3.55
  • Growth Rate Est. (year over year) +9.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
431.01 +2.82%
on 03/27/26
507.92 -12.75%
on 03/10/26
-53.67 (-10.80%)
since 02/27/26
3-Month
429.00 +3.30%
on 01/20/26
507.92 -12.75%
on 03/10/26
-19.74 (-4.26%)
since 12/26/25
52-Week
362.50 +22.25%
on 08/11/25
510.77 -13.24%
on 04/30/25
-49.53 (-10.05%)
since 03/28/25

Most Recent Stories

More News
1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down

1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down

CALY : 13.26 (-1.78%)
ARRY : 6.88 (-6.14%)
VRTX : 443.16 (+2.33%)
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

SYK : 326.10 (-0.41%)
VRTX : 443.16 (+2.33%)
CB : 325.35 (+1.96%)
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST

Featured Companies Include FreeCast (NASDAQ:CAST), KLED.ai, Lantern Pharma (NASDAQ:LTRN), and BlackBarn Restaurant

CAST : 3.90 (-2.01%)
RDZN : 1.0700 (unch)
SDST : 2.17 (-8.82%)
LTRN : 1.2350 (+10.27%)
VRTX : 443.16 (+2.33%)
NRXP : 2.09 (-4.57%)
DVLT : 0.5550 (-2.51%)
SGTM : 0.2382 (+9.37%)
CISO : 0.3221 (-2.10%)
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks

Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks

VRTX : 443.16 (+2.33%)
1 Momentum Stock to Research Further and 2 We Ignore

1 Momentum Stock to Research Further and 2 We Ignore

TH : 9.25 (-3.75%)
PNTG : 30.14 (+1.01%)
VRTX : 443.16 (+2.33%)
2 Reasons to Watch VRTX and 1 to Stay Cautious

2 Reasons to Watch VRTX and 1 to Stay Cautious

VRTX : 443.16 (+2.33%)
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc

Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc

TDOC : 5.14 (unch)
LASR : 54.00 (-16.04%)
MYGN : 4.36 (+1.87%)
VRTX : 443.16 (+2.33%)
NXT : 112.51 (-6.27%)
S&P Futures Waver as Middle East Conflict Uncertainty Persists, U.S. Inflation Data in Focus

March S&P 500 E-Mini futures (ESH26) are trending down -0.09% this morning, swinging between gains and losses as uncertainty surrounding the Middle East conflict remains high, while investors await key...

DDOG : 115.81 (+1.16%)
VRTX : 443.16 (+2.33%)
ORCL : 138.80 (-0.62%)
NKE : 51.24 (-0.25%)
TRI : 91.09 (+1.86%)
UNF : 249.33 (+0.29%)
ESH26 : 6,594.63s (-0.22%)
OXY : 66.24 (+1.41%)
APA : 43.74 (-1.46%)
0QWI.LN : 49.660 (+0.59%)
AVAV : 176.97 (-4.04%)
FANG : 198.65 (-1.58%)
US stocks hold steadier as Wall Street waits for the next signal on how long war with Iran may last

U.S. stocks held steadier as Wall Street waited for the next signal on when the war with Iran may end

$SPX : 6,343.72 (unch)
VRTX : 443.16 (+2.33%)
WST : 245.14 (+0.74%)
$DOWI : 45,216.14 (unch)
KSS : 12.20 (-2.09%)
$IUXX : 22,953.38 (unch)
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today

Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today

VRTX : 443.16 (+2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 458.68
2nd Resistance Point 451.16
1st Resistance Point 447.16
Last Price 443.16
1st Support Level 435.65
2nd Support Level 428.13
3rd Support Level 424.13

See More

52-Week High 510.77
Fibonacci 61.8% 454.13
Last Price 443.16
Fibonacci 50% 436.64
Fibonacci 38.2% 419.14
52-Week Low 362.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.